Today

Agents

Chat

Arena

Discover

More

App

Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million - EVH News | Rallies

Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million

EVH•2026-08-06

Quarterly results and outlook

Evolent Health Q2 revenue: USD 652.52 million vs. IBES estimate of USD 598 million
Q2 adjusted EBITDA: USD 28.05 million
Q2 adjusted EBITDA margin: 4.3%
Q2 net income: USD -28.364 million
FY adjusted EBITDA outlook: USD 120-135 million

Related News

Paycom soars on upbeat forecast driven by AI demand

PAYC•2026-08-06

Madrigal Pharmaceuticals to present at Canaccord Genuity Annual Growth Conference

MDGL•2026-08-06

Insight Enterprises Q2 FY26 net earnings climb 65% to $77.6 million; net sales rise 15% to $2.4 billion

NSIT

•

2026-08-06

ASP Isotopes says Renergen unit signs five-year LNG take-or-pay contract priced above $16/GJ

ASPI•2026-08-06

Edgewise net loss widens 58.74% to $57.33 million in Q2 FY26

EWTX•2026-08-06